News & Updates

ASCL1 a potential therapeutic target for treating Cushing’s disease
ASCL1 a potential therapeutic target for treating Cushing’s disease
20 Aug 2022

A recent study attempting to understand the pathogenesis of Cushing’s disease (CD) suggests the potential of achaete-scute complex homolog 1 (ASCL1), a pioneer transcription factor, as a therapeutic target for the treatment of CD.

ASCL1 a potential therapeutic target for treating Cushing’s disease
20 Aug 2022
Which factors predict relapse after antiviral therapy cessation in paediatric CHB?
Which factors predict relapse after antiviral therapy cessation in paediatric CHB?
19 Aug 2022